Schedule 13G ownership disclosure

Forte Biosciences Inc

COMMON STOCK · CUSIP: 34962G208

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Federated Hermes, Inc.

    Shares: 1,072,233.00 · Class: 8.78%

  • Voting Shares Irrevocable Trust

    Shares: 1,072,233.00 · Class: 8.78%

  • Thomas R. Donahue

    Shares: 1,072,233.00 · Class: 8.78%

  • Ann C. Donahue

    Shares: 1,072,233.00 · Class: 8.78%

  • J. Christopher Donahue

    Shares: 1,072,233.00 · Class: 8.78%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-25-000782
Form type
SCHEDULE 13G
Filer
FEDERATED HERMES, INC.
CIK
CIK 1056288
Filed
Jul 08, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub